Then abundant TanIIA-related genes with possible therapeutic effects on HCC were screened out through the network, such as ALB, JUN, MYC, SRC, ESR1, MMP9, PTGS2 and FOS, etc. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.